Related Experiment Video
Updated: Jan 26, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Recent advances in the management of diabetic retinopathy
Nabeela Dulull1, Faith Kwa2, Narin Osman3
1Discipline of Pharmacy, School Health and Biomedical Sciences, RMIT University, Bundoora, VIC3083, Australia.
Abstract:
Diabetic retinopathy (DR) is a microvascular complication of diabetes and is the leading cause of vision loss in people with diabetes. The current treatments do not target early stages of disease or impede disease progression. Therefore, the identification of new therapeutic targets, the development of novel therapies targeting early stages of the disease and accurate models that simulate pathological characteristics of this disorder are crucial. This review provides an overview of the pathological mechanisms underlying the development of DR, highlighting the recent advances in current and emerging treatments for DR.
Insights
Diabetic retinopathy (DR) is a leading cause of vision loss. New treatments are needed to target early stages and slow progression, requiring identification of novel therapeutic targets and accurate disease models.
Area of Science:
- Ophthalmology
- Endocrinology
- Vascular Biology
Background:
- Diabetic retinopathy (DR) is a significant microvascular complication of diabetes.
- It is the primary cause of vision loss among diabetic individuals.
- Current treatments are insufficient for early-stage disease or halting progression.
Purpose of the Study:
- To review the pathological mechanisms of diabetic retinopathy development.
- To highlight recent advances in current and emerging treatments for DR.
- To emphasize the need for new therapeutic targets and accurate disease models.
Main Methods:
- Literature review of pathological mechanisms in DR.
- Analysis of current therapeutic strategies for DR.
- Exploration of emerging treatments and research directions for DR.
Main Results:
- Detailed overview of the pathological pathways contributing to DR.
- Summary of established treatments and their limitations.
- Identification of promising novel therapeutic targets and approaches.
Conclusions:
- Effective management of diabetic retinopathy requires targeting early disease stages.
- Further research into novel therapies and accurate disease models is crucial.
- Advancements in understanding DR pathology are paving the way for improved treatments.
More Related Videos
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Extraction: Advanced Methods
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Psychoneuroimmunology: Diabetes and Cancer